FMNL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.402320E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.211600E-02
Normal-vs-Stage2
2.428400E-02
Normal-vs-Stage3
7.120100E-02
Normal-vs-Stage4
9.808100E-02
Stage1-vs-Stage2
5.715800E-01
Stage1-vs-Stage3
2.153000E-01
Stage1-vs-Stage4
4.521600E-01
Stage2-vs-Stage3
1.121500E-03
Stage2-vs-Stage4
7.156400E-01
Stage3-vs-Stage4
6.642100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.316130E-02
Normal-vs-AfricanAmerican
2.145600E-01
Normal-vs-Asian
4.301700E-02
Caucasian-vs-AfricanAmerican
4.850800E-01
Caucasian-vs-Asian
6.483200E-01
AfricanAmerican-vs-Asian
4.666600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.184320E-02
Normal-vs-Female
2.338100E-02
Male-vs-Female
8.431000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.047900E-02
Normal-vs-Age(41-60Yrs)
2.379700E-02
Normal-vs-Age(61-80Yrs)
1.832070E-02
Normal-vs-Age(81-100Yrs)
1.167830E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.144400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.674400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.206800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.537200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.525190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.644400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.397460E-03
Normal-vs-Daily Drinker
5.955700E-03
Normal-vs-Weekly Drinker
2.523600E-01
Normal-vs-Occasional Drinker
4.038100E-02
Normal-vs-Social Drinker
6.904000E-02
Non Drinker-vs-Daily Drinker
9.502200E-01
Non Drinker-vs-Weekly Drinker
2.536600E-01
Non Drinker-vs-Occasional Drinker
3.304400E-01
Non Drinker-vs-Social Drinker
4.307800E-02
Daily Drinker-vs-Weekly Drinker
2.572000E-01
Daily Drinker-vs-Occasional Drinker
3.757600E-01
Daily Drinker-vs-Social Drinker
7.371900E-02
Weekly Drinker-vs-Occasional Drinker
5.653800E-01
Weekly Drinker-vs-Social Drinker
9.802200E-01
Occasional Drinker-vs-Social Drinker
4.168400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.344600E-01
Normal-vs-Grade 2
9.171700E-02
Normal-vs-Grade 3
1.024350E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.779300E-03
Grade 1-vs-Grade 3
9.475100E-03
Grade 1-vs-Grade 4
3.344600E-01
Grade 2-vs-Grade 3
9.212600E-01
Grade 2-vs-Grade 4
9.171700E-02
Grade 3-vs-Grade 4
1.024350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.326400E-02
Normal-vs-NonDiabetic
4.204400E-03
Diabetic-vs-NonDiabetic
9.742200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.478310E-02
Normal-vs-NoPancreatitis
1.039790E-02
Pancreatitis-vs-NoPancreatitis
5.978600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.336500E-03
Normal-vs-N1
2.142300E-02
N0-vs-N1
3.130600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.383700E-03
Normal-vs-TP53-NonMutant
1.169690E-02
TP53-Mutant-vs-TP53-NonMutant
6.686000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
